These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9730714)

  • 61. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of erythropoietin, active vitamin D3 metabolites, and alkali agents in predialysis patients.
    Ismail N
    Semin Nephrol; 1997 Jul; 17(4):270-84. PubMed ID: 9241713
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation].
    Kakuhara T; Mizoguchi M; Itoh M; Nagasawa M; Mori T; Ohtsuka K; Kubota M; Minatoguchi T; Ohara K; Yoshida M; Koide H; Ohno J
    Nihon Jinzo Gakkai Shi; 1982 Jun; 24(6):693-704. PubMed ID: 7176180
    [No Abstract]   [Full Text] [Related]  

  • 64. [Chronic renal failure causes bone fragility and blood vessel stiffening].
    Keronen S; Martola L; Honkanen E
    Duodecim; 2012; 128(5):465-74. PubMed ID: 22486062
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Levels of vitamin A in the serum in dialyzed patients with renal osteopathy].
    Sotorník I; Nováková V; Dráb K; Zichová M; Povýsil C; Mrhová O; Růzicková J; Táborský P; Reitschlägerová V
    Cas Lek Cesk; 1988 Aug; 127(33):1037-42. PubMed ID: 3180168
    [No Abstract]   [Full Text] [Related]  

  • 66. [Renal osteodystrophy during chronic dialysis and transplantation].
    Fournier A; Bordier P; Weil B; Safar M; Idatte JM
    Presse Med (1893); 1971 Oct; 79(45):2007-8. PubMed ID: 4940843
    [No Abstract]   [Full Text] [Related]  

  • 67. [Adequate Ca level for dialysis patient (study on medical therapy for secondary hyperparathyroidism in dialysis patient)].
    Sawada K; Sawada S; Nakagawa M; Ioka J; Tatsumi T; Yoneda Y; Maki K
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):813-9. PubMed ID: 1479721
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical study on the disturbances in calcium and bone disease: renal osteodystrophy in patients with chronic renal failure].
    Yoshidome E
    Igaku Kenkyu; 1987 May; 57(2):83-104. PubMed ID: 3673482
    [No Abstract]   [Full Text] [Related]  

  • 69. [Evaluation of bone mineralization in patients on maintenance hemodialysis].
    Sladowska B; Gellert R; Ostrowski K
    Pol Arch Med Wewn; 1994; 92 Spec No():85-91. PubMed ID: 7731904
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Therapy success in the treatment of severe renal osteopathy as the result of effective interdisciplinary team work. Case report].
    Engelmann L; Gummel J; Gellert S; Mau H
    Beitr Orthop Traumatol; 1990 Mar; 37(3):172-6. PubMed ID: 2375742
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Renal osteodystrophy.
    Bardin T
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):114S-118S. PubMed ID: 9273952
    [No Abstract]   [Full Text] [Related]  

  • 72. [Infectious osseous complications in patients on chronic hemodialysis therapy].
    Vĕsín S; Sulková S
    Cesk Radiol; 1985 May; 39(3):173-80. PubMed ID: 4028276
    [No Abstract]   [Full Text] [Related]  

  • 73. [Complications suffered by dialysis patients. 3. Ca and P metabolism disorders of bone].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1358-65. PubMed ID: 11032503
    [No Abstract]   [Full Text] [Related]  

  • 74. Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
    Maxwell DR; Benjamin DM; Donahay SL; Allen MK; Hamburger RJ; Luft FC; Kleit SA
    Proc Clin Dial Transplant Forum; 1977; 7():166-9. PubMed ID: 210446
    [No Abstract]   [Full Text] [Related]  

  • 75. Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial.
    Massart A; Debelle FD; Racapé J; Gervy C; Husson C; Dhaene M; Wissing KM; Nortier JL
    Am J Kidney Dis; 2014 Nov; 64(5):696-705. PubMed ID: 24856872
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Current status of chronic dialysis and its several complications].
    Hara K
    Nihon Ika Daigaku Zasshi; 1992 Oct; 59(5):433-6. PubMed ID: 1430116
    [No Abstract]   [Full Text] [Related]  

  • 77. Bone disease in chronic renal failure.
    Carroll RN
    Br Med J; 1972 Nov; 4(5836):366. PubMed ID: 4637534
    [No Abstract]   [Full Text] [Related]  

  • 78. Forgotten signs of chronic kidney disease-associated mineral bone disease.
    Hunter PG; Miller-Hodges E; Hunter RW; Dhaun N
    QJM; 2020 May; 113(5):359-360. PubMed ID: 31411332
    [No Abstract]   [Full Text] [Related]  

  • 79. Intradental lesions and their reversal in a patient being treated for end-stage renal disease.
    Hutton CE
    Oral Surg Oral Med Oral Pathol; 1985 Sep; 60(3):258-61. PubMed ID: 3862036
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recent advances in the management of the infant, child, and adolescent with chronic renal failure.
    Fine RN
    Pediatr Rev; 1990 Mar; 11(9):277-83. PubMed ID: 2408029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.